Logo image of COP.DE

COMPUGROUP MEDICAL SE & CO K (COP.DE) Stock Fundamental Analysis

FRA:COP - Deutsche Boerse Ag - DE000A288904 - Common Stock - Currency: EUR

22.18  +0.1 (+0.45%)

Fundamental Rating

3

Overall COP gets a fundamental rating of 3 out of 10. We evaluated COP against 10 industry peers in the Health Care Technology industry. While COP is still in line with the averages on profitability rating, there are concerns on its financial health. COP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COP had positive earnings in the past year.
In the past year COP had a positive cash flow from operations.
COP had positive earnings in each of the past 5 years.
Each year in the past 5 years COP had a positive operating cash flow.
COP.DE Yearly Net Income VS EBIT VS OCF VS FCFCOP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a Return On Assets value of 1.34%, COP perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
COP has a Return On Equity (4.15%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.53%, COP is doing worse than 60.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for COP is below the industry average of 7.31%.
Industry RankSector Rank
ROA 1.34%
ROE 4.15%
ROIC 3.53%
ROA(3y)2.65%
ROA(5y)3.3%
ROE(3y)7.71%
ROE(5y)9.17%
ROIC(3y)4.07%
ROIC(5y)4.45%
COP.DE Yearly ROA, ROE, ROICCOP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 2.34%, COP is in line with its industry, outperforming 50.00% of the companies in the same industry.
COP's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 8.13%, COP is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
In the last couple of years the Operating Margin of COP has declined.
The Gross Margin of COP (83.85%) is better than 70.00% of its industry peers.
COP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.13%
PM (TTM) 2.34%
GM 83.85%
OM growth 3Y-2.61%
OM growth 5Y-10.29%
PM growth 3Y-23.61%
PM growth 5Y-19.42%
GM growth 3Y32.01%
GM growth 5Y16.44%
COP.DE Yearly Profit, Operating, Gross MarginsCOP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

2

2. Health

2.1 Basic Checks

COP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
COP has less shares outstanding than it did 1 year ago.
COP has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, COP has a worse debt to assets ratio.
COP.DE Yearly Shares OutstandingCOP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
COP.DE Yearly Total Debt VS Total AssetsCOP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

COP has an Altman-Z score of 1.77. This is a bad value and indicates that COP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of COP (1.77) is comparable to the rest of the industry.
COP has a debt to FCF ratio of 9.74. This is a negative value and a sign of low solvency as COP would need 9.74 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.74, COP perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
COP has a Debt/Equity ratio of 1.22. This is a high value indicating a heavy dependency on external financing.
COP has a Debt to Equity ratio of 1.22. This is amonst the worse of the industry: COP underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.74
Altman-Z 1.77
ROIC/WACC0.68
WACC5.21%
COP.DE Yearly LT Debt VS Equity VS FCFCOP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

COP has a Current Ratio of 1.12. This is a normal value and indicates that COP is financially healthy and should not expect problems in meeting its short term obligations.
COP has a Current ratio of 1.12. This is in the lower half of the industry: COP underperforms 60.00% of its industry peers.
A Quick Ratio of 1.09 indicates that COP should not have too much problems paying its short term obligations.
COP's Quick ratio of 1.09 is on the low side compared to the rest of the industry. COP is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 1.09
COP.DE Yearly Current Assets VS Current LiabilitesCOP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for COP have decreased strongly by -45.71% in the last year.
COP shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.58% yearly.
Looking at the last year, COP shows a decrease in Revenue. The Revenue has decreased by -2.19% in the last year.
Measured over the past years, COP shows a quite strong growth in Revenue. The Revenue has been growing by 9.12% on average per year.
EPS 1Y (TTM)-45.71%
EPS 3Y-20.77%
EPS 5Y-13.58%
EPS Q2Q%-40%
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y4.02%
Revenue growth 5Y9.12%
Sales Q2Q%0.54%

3.2 Future

Based on estimates for the next years, COP will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.19% on average per year.
COP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.72% yearly.
EPS Next Y1.4%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue Next Year2.47%
Revenue Next 2Y2.65%
Revenue Next 3Y2.49%
Revenue Next 5Y0.72%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COP.DE Yearly Revenue VS EstimatesCOP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M 1B
COP.DE Yearly EPS VS EstimatesCOP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 42.65 indicates a quite expensive valuation of COP.
COP's Price/Earnings is on the same level as the industry average.
COP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.32.
COP is valuated correctly with a Price/Forward Earnings ratio of 12.61.
70.00% of the companies in the same industry are more expensive than COP, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.19. COP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 42.65
Fwd PE 12.61
COP.DE Price Earnings VS Forward Price EarningsCOP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

70.00% of the companies in the same industry are more expensive than COP, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, COP is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.04
EV/EBITDA 9.09
COP.DE Per share dataCOP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)30.37
PEG (5Y)N/A
EPS Next 2Y4.91%
EPS Next 3Y9.19%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.23%, COP is not a good candidate for dividend investing.
COP's Dividend Yield is comparable with the industry average which is at 3.04.
Compared to an average S&P500 Dividend Yield of 2.40, COP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.23%

5.2 History

The dividend of COP is nicely growing with an annual growth rate of 14.75%!
Dividend Growth(5Y)14.75%
Div Incr Years2
Div Non Decr Years3
COP.DE Yearly Dividends per shareCOP.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

COP pays out 191.63% of its income as dividend. This is not a sustainable payout ratio.
COP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP191.63%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
COP.DE Yearly Income VS Free CF VS DividendCOP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
COP.DE Dividend Payout.COP.DE Dividend Payout, showing the Payout Ratio.COP.DE Dividend Payout.PayoutRetained Earnings

COMPUGROUP MEDICAL SE & CO K

FRA:COP (6/17/2025, 5:28:42 PM)

22.18

+0.1 (+0.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-31 2025-07-31
Inst Owners13.38%
Inst Owner ChangeN/A
Ins Owners53.51%
Ins Owner ChangeN/A
Market Cap1.19B
Analysts56.67
Price Target21.32 (-3.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.23%
Yearly Dividend1
Dividend Growth(5Y)14.75%
DP191.63%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.9%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 42.65
Fwd PE 12.61
P/S 1.03
P/FCF 14.04
P/OCF 8.28
P/B 1.83
P/tB N/A
EV/EBITDA 9.09
EPS(TTM)0.52
EY2.34%
EPS(NY)1.76
Fwd EY7.93%
FCF(TTM)1.58
FCFY7.12%
OCF(TTM)2.68
OCFY12.08%
SpS21.51
BVpS12.12
TBVpS-12.86
PEG (NY)30.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.34%
ROE 4.15%
ROCE 5.85%
ROIC 3.53%
ROICexc 3.83%
ROICexgc 41.76%
OM 8.13%
PM (TTM) 2.34%
GM 83.85%
FCFM 7.35%
ROA(3y)2.65%
ROA(5y)3.3%
ROE(3y)7.71%
ROE(5y)9.17%
ROIC(3y)4.07%
ROIC(5y)4.45%
ROICexc(3y)4.31%
ROICexc(5y)4.74%
ROICexgc(3y)36.56%
ROICexgc(5y)51.39%
ROCE(3y)6.74%
ROCE(5y)7.38%
ROICexcg growth 3Y-23.91%
ROICexcg growth 5Y-9.04%
ROICexc growth 3Y-4.3%
ROICexc growth 5Y-14.26%
OM growth 3Y-2.61%
OM growth 5Y-10.29%
PM growth 3Y-23.61%
PM growth 5Y-19.42%
GM growth 3Y32.01%
GM growth 5Y16.44%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.74
Debt/EBITDA 3.86
Cap/Depr 52.61%
Cap/Sales 5.11%
Interest Coverage 2.54
Cash Conversion 69.81%
Profit Quality 314.42%
Current Ratio 1.12
Quick Ratio 1.09
Altman-Z 1.77
F-Score6
WACC5.21%
ROIC/WACC0.68
Cap/Depr(3y)60.99%
Cap/Depr(5y)64.22%
Cap/Sales(3y)5.98%
Cap/Sales(5y)6.31%
Profit Quality(3y)175.79%
Profit Quality(5y)158.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-45.71%
EPS 3Y-20.77%
EPS 5Y-13.58%
EPS Q2Q%-40%
EPS Next Y1.4%
EPS Next 2Y4.91%
EPS Next 3Y9.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.19%
Revenue growth 3Y4.02%
Revenue growth 5Y9.12%
Sales Q2Q%0.54%
Revenue Next Year2.47%
Revenue Next 2Y2.65%
Revenue Next 3Y2.49%
Revenue Next 5Y0.72%
EBIT growth 1Y-18.88%
EBIT growth 3Y1.31%
EBIT growth 5Y-2.11%
EBIT Next Year77.58%
EBIT Next 3Y24.98%
EBIT Next 5Y17.79%
FCF growth 1Y3.01%
FCF growth 3Y-11.08%
FCF growth 5Y-0.24%
OCF growth 1Y-8.49%
OCF growth 3Y-7.96%
OCF growth 5Y3.13%